The UNAIDS annual report warns that Trump era HIV funding cuts could lead to 6 million more infections and 4 million deaths ...

HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.

A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

U.S. HIV funding cuts risk reversing decades of progress, potentially causing over 4 million AIDS-related deaths and 6 ...

Lenacapavir is available in both oral tablet form and as subcutaneous injections. It is available as oral tablets and ...